A panel of experts and leaders across healthcare, biopharma, and high tech will explore how to break down silos and think like a learning health ecosystem.

The pharmaceutical industry traditionally tests excipient compatibility by incubating binary mixtures of API and excipient at stress conditions and testing over time by HPLC. These tests take up to 3 months to complete, slowing the progress of formulation development. DSC/MDSC analysis is a better technique over HPLC as it is faster, can detect chemical and physical changes, and is more ecofriendly using less materials.

Kate Rawson, one of the most insightful and practical observers of the health policy scene in Washington, offers the Coalition for Healthcare Communication her well-informed analysis and a Q&A format.

Join this webinar to hear from regulatory affairs professionals, pharmaceutical company executives and leaders in data and AI as they discuss the challenges and opportunities for RWE across the drug lifecycle and lessons learned building successful RWE analytics programs.

The pharmaceutical and life science industries have experienced unique challenges over the course of the pandemic, requiring a critical need for flexibility and collaboration amongst all stakeholders throughout the clinical trial ecosystem. In this complimentary webinar, expert speakers will discuss current operational obstacles and explore strategic solutions to optimize a supply chain strategy in the years ahead.

Cannabis Science and Technology is hosting the 2nd annual Hemp Science & Technology Virtual Symposium November 30-December 1, 2021.

tec5USA, a leading designer and manufacturer of in-line process spectrometers, announced plans to host a free webinar on November 10th discussing the growing problem of counterfeit medications and their handheld solution for detection.

This free-to-attend event features tangible takeaways and tailored sessions to maximize e-prescribing and EHR technology engagement for optimal communication. Plus, benefit from Q&As with the speakers following the session.

​In this webinar, a panel of experts will discuss whether autologous therapies here to stay; if allogeneic therapies are the future; and the unlimited scope of gene editing technologies.

This interactive discussion will touch on a wide range of issues, from how the Covid-19 pandemic has affected women’s health globally, to the current state of sexual and reproductive health and rights, and how changing our approach to data can expose important drivers of poor health in women.